Journals / Anatolian Current Medical Journal / 2019 / Cilt: 1 - Sayı: 3

A mortal Crimean Congo hemorrhagic fever (CCHF) case in the season of winter

Kış mevsiminde görülen ve mortal seyreden bir Kırım Kongo kanamalı ateşi (KKKA) olgusu

Pages
77–80
Publication Date
2019-07-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, we present a 61-year-old male patient who was followed up in our clinic in february with a diagnosis of CCHF.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Crimean Congo hemorrhagic fever (CCHF) is a disease that is usually seen in spring and summer months and is endemic in certain geography in our country.
📊
Key Findings & Data:Crimean Congo hemorrhagic fever (CCHF) is a disease that is usually seen in spring and summer months and is endemic in certain geography in our country.
💡
Conclusion & Impact:In this article, we present a 61-year-old male patient who was followed up in our clinic in february with a diagnosis of CCHF.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Kırım Kongo kanamalı ateş · mevsimsel özellik · olgu sunumu

Abstract

Crimean Congo hemorrhagic fever (CCHF) is a disease that is usually seen in spring and summer months and is endemic in certain geography in our country. In this article, we present a 61-year-old male patient who was followed up in our clinic in february with a diagnosis of CCHF.

Özet

Kırım Kongo kanamalı ateşi (KKKA) sıklıkla ilkbahar-yaz dönemlerinde, nisan ile eylül ayları arasında görülen ve ülkemizde belirli coğrafyada endemik seyreden bir hastalıktır. Bu yazıda KKKA tanısı ile kış mevsiminde, şubat ayında servisimizde izlenen ve mortal seyreden 61 yaşında bir erkek hasta sunuldu.

🔖

Cite This Article

ARSLAN, K., KILIÇ, E. K., CESUR, S., HATİPOĞLU, Ç. A., BULUT, C., KINIKLI, S. (2019). A mortal Crimean Congo hemorrhagic fever (CCHF) case in the season of winter. Anatolian Current Medical Journal, Cilt: 1 - Sayı: 3, 77–80. https://ajindex.com/articles/733912

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Bölük G, Özvatan Şener T, Yılmaz E, Akalın H, Mıstık R, Helvacı S. Güney Marmara’da Kırım-Kongo kanamalı ateşi. Klimik Derg 2009; 22: 100-2
  2. Çevik FÇ, Naz H, Aykın N, Korkmaz P. Kırım-Kongo kanamalı ateşi: geç tanı konulan iki olgu. Flora 2011; 16: 180-3
  3. Ergönül Ö. Kırım-Kongo Kanamalı Ateşi. ANKEM Derg 2009; 23: 234-40
  4. Kırım-Kongo Kanamalı Ateşi. Ankara: Sağlık Bakanlığı Temel Sağlık Hizmetleri Genel Müdürlüğü (erişim 25 Eylül 2009).
  5. Koç MM, Willke A. Kocaeli'de uzun inkübasyon süreli sporadik Kırım-Kongo kanamalı ateşi olgusu. Mikrobiyol Bul 2012; 46: 129-33
  6. Ansari H, Shahbaz B, Izadi S, et al. Crimean-Congo hemorrhagic fever and its relationship with climate factors in southeast Iran: a 13-year experience. J Infect Dev Ctries 2014; 8: 749-57
  7. Sharififard M, Alavi SM, Salmanzadeh S, Safdari F, Kamali A. Epidemiological survey of Crimean-Congo hemorrhagic fever (CCHF), a Fatal ınfectious disease in Khuzestan Province, Southwest Iran, During 1999 – 2015. Jundishapur J Microbiol 2016; 9: e30883
  8. Yılmaz GR, Buzgan T, Irmak H, et al. The epidemiology of Crimean-Congo hemorrhagic fever in Turkey, 2002–2007. Int J Infect Dis 2009; 13: 380-6
  9. Swanepoel R, Gill DE, Shepherd AJ, et al. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev Infect Dis. 1989;11 Suppl 4:S794-800
  10. Kazancioğlu S, Akinci E, Baştuğ A, et al. Does the course of laboratory parameters help us to predict the outcome of CCHF? Turk J Med Sci 2016; 46: 328-34
  11. Gurbuz Y, Ozturk B, Tutuncu EE, Sencan I, Cicek Senturk G, Altay FA. Evaluation of prognostic values of tissue plasminogen activator and plasminogen activator ınhibitor-1 in Crimean-Congo hemorrhagic fever patients. Jundishapur J Microbiol 2015; 8: e26514
  12. Dokuzoguz B, Celikbas AK, Gök ŞE, Baykam N, Eroglu MN, Ergönül Ö. Severity scoring index for Crimean-Congo hemorrhagic fever and the impact of ribavirin and corticosteroids on fatality. Clin Infect Dis 2013; 57: 1270-4
  13. Akinci E, Bodur H, Sunbul M, Leblebicioglu H. Prognostic factors, pathophysiology and novel biomarkers in Crimean-Congo hemorrhagic fever. Antiviral Res 2016; 132: 233-43
  14. Vorou RM. Crimean-Congo hemorrhagic fever in southeastern Europe Int J Infect Dis 2009; 13: 659-62.